Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Milan S. Blake"'
Autor:
Milan S. Blake, R. Burton, Nathalie Durant, Kathrin U. Jansen, J. Raab, Charles E. Rose, J. Lin, L. Lee, Lindsey Ashton, Ian M. Feavers, L. Katz, Brian D. Plikaytis, Daniel S. Schmidt, David Goldblatt, Peter C. Giardina, Sandra Romero-Steiner, Philip Fernsten, Moon H. Nahm, L. Kierstead, Mustafa Akkoyunlu, George M. Carlone, Joseph M. Antonello, R. Care, F. Fievet, Jean-François Maisonneuve, Jack T. Stapleton
Publikováno v:
Clinical and Vaccine Immunology. 18:1728-1736
Lot 89SF has been the reference standard serum pool used in pneumococcal enzyme-linked immunosorbent assays (ELISAs) since 1990. In 2005, it was estimated that there remained between 2 and 5 years' supply of lot 89SF. Since lot 89SF was the reference
Autor:
Dennis J. Kopecko, Tod J. Merkel, Yanping Wu, Siba Bhattacharyya, Milan S. Blake, Sunil Singh, Manuel Osorio
Publikováno v:
Infection and Immunity. 77:1475-1482
Bacillus anthracis , the etiological agent of anthrax disease, is a proven weapon of bioterrorism. Currently, the only licensed vaccine against anthrax in the United States is AVA Biothrax, which, although efficacious, suffers from several limitation
Autor:
Xinle Cui, Can Kocabas, Margaret N. Kennedy, Sunita Kanswal, Mustafa Akkoyunlu, Milan S. Blake, David M. Segal, Nora Katsenelson
Publikováno v:
Cellular Microbiology. 9:1297-1310
Encapsulated Neisseria meningitidis can invade mucosal barriers and cause systemic diseases. Activation of the innate immune system by conserved meningococcal molecules such as lipooligosaccharides (LOS) is essential for the generation of an effectiv
Autor:
Milan S. Blake, John Kim, Francis Michon, Samuel L. Moore, B. Mario Pinto, France-Isabelle Auzanneau, Blair D. Johnston, Margaret A. Johnson
Publikováno v:
Infection and Immunity. 73:6383-6389
A number of epitope specificities associated with the cell wall polysaccharide antigen of group A streptococci were identified in a polyclonal rabbit antiserum induced in rabbits by whole group A streptococci and in polyclonal convalescent human anti
Autor:
Milan S. Blake, Sang Uk-Nham, J G Cannon, Eric J. Brown, Michael A. Apicella, Jennifer L. Edwards
Publikováno v:
Cellular Microbiology. 4:571-584
Little is known about the pathogenesis of gonococcal infection within the lower female genital tract. We recently described the distribution of complement receptor 3 (CR3) on epithelia of the female genital tract. Our studies further indicate that CR
Publikováno v:
Journal of Microbiological Methods. 49:97-101
A one-step method to chemically transform non-piliated Neisseria meningitidis strains previously resistant to conventional electrochemical transformation procedures has been developed. This method has been used to generate genetically engineered meni
Autor:
Milan S. Blake
Publikováno v:
Pneumococcal Vaccines
The first industrially produced pneumococcal polysaccharide (PS) vaccine was made under contract from NIAID to Eli Lilly and Company. The source of the strains for this vaccine was the American Type Culture Collection (ATCC), which in essence generat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc3b286d041518bf431e66d68e9193d5
https://doi.org/10.1128/9781555815820.ch12
https://doi.org/10.1128/9781555815820.ch12
Autor:
Milan S. Blake, Peter C. Giardina, Kuo-Kuang Wen, Michael A. Apicella, Peter A. Rubenstein, Jennifer L. Edwards
Publikováno v:
Biochemistry. 39:8638-8647
The invasion of epithelial cells by N. gonorrheae is accompanied by formation of a halo of actin filaments around the enveloped bacterium. The transfer of the bacterial major outer membrane protein, porin, to the host cell membrane during invasion ma
Autor:
Milan S. Blake, Fiona G. Mackinnon, Mohammed H. Sayegh, Yu Ho, Francis Michon, Anil Chandraker, Lee M. Wetzler
Publikováno v:
The Journal of Infectious Diseases. 180:755-761
A T cell-dependent immune response to group C meningococcal capsular polysaccharide (CPS) can be elicited when CPS is conjugated to the class 3 neisserial porin (CPS-porin). Treatment of CPS-porin-immunized mice with B7-2 blocking monoclonal antibody